Regenerative Medical Technology (RMTG) EBITDA (2019 - 2026)
Regenerative Medical Technology's EBITDA came in at $656,787 for Q2 2026, compared with -$195,255 a year earlier and up 100.6% from the prior quarter.
Regenerative Medical Technology (RMTG) EBITDA (2019 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Regenerative Medical Technology reported EBITDA of $406,650, down 10.2% year-over-year; for FY2025, it was -$586,095.
- Going back by year, EBITDA was $301,740 in FY2024, -$405,124 in FY2023, -$1.03 million in FY2022 and -$9.88 million in FY2021.
- The Q2 2026 figure represents the highest quarterly EBITDA in data going back to Q1 2019.
- Business Quant data shows RMTG's EBITDA at $327,477 (Q1 2026), -$207,931 (Q4 2025) and -$369,683 (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 12.29 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 9.10 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 8.33 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 999.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 5.09 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 4.63 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -9.70 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 5.89 Bn |
| 10 | Regenerative Medical Technology | 549,558.71 | -3.98 Mn | 2.58 Mn | 1.00 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.00 Mn |
| Mar 31, 2026 | 1.06 Mn |
| Dec 31, 2025 | 582,083.00 |
| Sep 30, 2025 | 148,730.00 |
| Jun 30, 2025 | -195,255.00 |
| Mar 31, 2025 | 186,774.00 |
| Dec 31, 2024 | 357,193.00 |
| Sep 30, 2024 | 174,552.00 |
| Jun 30, 2024 | 900,429.00 |
| Mar 31, 2024 | 996,245.00 |
| Dec 31, 2023 | 725,977.00 |
| Sep 30, 2023 | 788,266.00 |
| Jun 30, 2023 | 392,167.00 |
| Mar 31, 2023 | 748,380.00 |
| Dec 31, 2022 | 372,935.00 |
| Sep 30, 2022 | 313,389.00 |
| Jun 30, 2022 | 108,605.00 |
| Mar 31, 2022 | -70,285.00 |
| Dec 31, 2021 | -75,433.00 |
| Sep 30, 2021 | -8.72 Mn |
Regenerative Medical Technology EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=RMTG&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "RMTG", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=RMTG&period=max&api_key=YOUR_API_KEY");
const data = await res.json();